​

​

Year ended

​

Year ended

​

​

December 31, 2025

​

December 31, 2024

​

​

Number of

​

Weighted

​

Weighted

​

Number of

​

Weighted

​

Weighted

​

​

Restricted

​

Average

​

Average

​

Restricted

​

Average

​

Average

​

​

Shares

​

Remaining Life

​

Grant Date

​

Shares

​

Remaining Life

​

Grant Date

​

  ​ ​ ​

Outstanding

  ​ ​ ​

(years)

  ​ ​ ​

Fair Value

  ​ ​ ​

Outstanding

  ​ ​ ​

(years)

  ​ ​ ​

Fair Value

Balance non-vested Restricted Stock at beginning of period

​

560,970

​

1.61

​

$

5.77

​

491,536

​

1.74

​

$

5.59

Granted

​

488,283

​

1.50

​

​

4.78

​

300,052

​

1.92

​

​

5.97

Vested

​

(267,461)

​

—

​

​

5.60

​

(230,618)

​

—

​

​

5.65

Balance non-vested Restricted Stock at end of period

​

781,792

​

1.71

​

$

5.06

​

560,970

​

1.61

​

$

5.77